Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // March 12th, 2010 // 7:35 am
There are gray skies hovering over the Pharmalot corporate campus this morning, but our spirits are sunny. And why not? If nothing else, the weekend is just around the corner. Yes, there are deadlines and meetings between now and then, but still, we look ahead to spending time with the short people and catching up on our to-do list. What will you do? While you ponder, here are a few items to help you along. Whatever your choice, have a nice weekend…
Birth Control Pills May Help Women Live Longer (Bloomberg News)
Nigerian Start-Up Fights Counterfeit Drugs (The Wall Street Journal)
Arena Will Launch Diet Drug With Or Without A Partner (Reuters)
Roche’s Avastin Fails Prostate Cancer Study Goal (Bloomberg News)
Merck’s Vytorin Effectiveness Study To Continue (Associated Press)
Pfizer’s Sutent Fails Breast Cancer Trials (Reuters)
photo thx to tipiro on Flickr creative commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Arena Pharmaceuticals, Avastin, Birth Control, Breast Cancer, Cholesterol, Counterfeit Drugs, Counterfeits, Diet Pills, Merck, Nigeria, Obesity, Pfizer, Prostate Cancer, Roche, Sutent, Vytorin